Endovascular Engineering Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$80M
- Investors
-
12
Endovascular Engineering General Information
Description
Developer of a minimally invasive thrombectomy system designed to remove pulmonary embolisms efficiently while minimizing patient risk. The company offers a small-profile catheter that combines a self-expanding funnel for wide distal clot engagement, dual-action technology that simultaneously agitates and aspirates clots, and integrated navigation controls that allow physicians to maneuver safely through complex vascular pathways, providing precise, controlled, and efficient clot removal during a single procedure, enabling interventional physicians to achieve effective large-bore clot engagement and safe, single-pass procedures through complex vascular anatomies.
Contact Information
Website
www.endovascularengineering.comCorporate Office
- 3925 Bohannon Drive
- Suite 300
- Menlo Park, CA 94025
- United States
Corporate Office
- 3925 Bohannon Drive
- Suite 300
- Menlo Park, CA 94025
- United States
Endovascular Engineering Timeline
Endovascular Engineering Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 07-Apr-2026 | $80M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series B) | 14-Feb-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 02-Apr-2022 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A) | 22-Nov-2020 | $4M | $4M | Completed | Startup | |
| 1. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup |
Endovascular Engineering Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-2 | ||||||||
| Series C-1 | ||||||||
| Series B3 | ||||||||
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series A1 | 9,476,060 | $0.000100 | 8% | $1.82 | $1.82 | 1x | $1.82 | 4.05% |
| Series A | 4,200,000 | $0.000100 | $1 | $1 | 1x | $1 | 1.79% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Endovascular Engineering Comparisons
Industry
Financing
Details
Endovascular Engineering Competitors (2)
One of Endovascular Engineering’s 2 competitors is Jupiter Endovascular, a Venture Capital-Backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Jupiter Endovascular | Venture Capital-Backed | Menlo Park, CA | ||||
| NeuroVasc Technologies | Venture Capital-Backed | Irvine, CA |
Endovascular Engineering Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Endovascular Engineering Patents
Endovascular Engineering Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12440615-B1 | Blood transfusion for thrombectomy devices, and systems and methods thereof | Active | 28-Oct-2024 | ||
| US-12611499-B1 | Blood transfusion for thrombectomy devices, and systems and methods thereof | Active | 28-Oct-2024 | ||
| US-20260115371-A1 | Blood transfusion for thrombectomy devices, and systems and methods thereof | Active | 28-Oct-2024 | ||
| US-20260263680-A1 | Blood transfusion for thrombectomy devices, and systems and methods thereof | Pending | 28-Oct-2024 | ||
| US-20260295138-A1 | Blood transfusion for thrombectomy devices, and systems and methods thereof | Pending | 28-Oct-2024 | A61M1/60 |
Endovascular Engineering Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Endovascular Engineering Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gilde Healthcare | PE/Buyout | Minority | ||
| Norwest | Venture Capital | Minority | ||
| 415 Capital | Venture Capital | Minority | ||
| Inventure Group | Accelerator/Incubator | Minority | ||
| M&L Group | Venture Capital | Minority |
Endovascular Engineering FAQs
-
When was Endovascular Engineering founded?
Endovascular Engineering was founded in 2019.
-
Where is Endovascular Engineering headquartered?
Endovascular Engineering is headquartered in Menlo Park, CA.
-
What is the size of Endovascular Engineering?
Endovascular Engineering has 40 total employees.
-
What industry is Endovascular Engineering in?
Endovascular Engineering’s primary industry is Surgical Devices.
-
Is Endovascular Engineering a private or public company?
Endovascular Engineering is a Private company.
-
What is the current valuation of Endovascular Engineering?
The current valuation of Endovascular Engineering is .
-
What is Endovascular Engineering’s current revenue?
The current revenue for Endovascular Engineering is .
-
How much funding has Endovascular Engineering raised over time?
Endovascular Engineering has raised $141M.
-
Who are Endovascular Engineering’s investors?
Gilde Healthcare, Norwest, 415 Capital, Inventure Group, and M&L Group are 5 of 12 investors who have invested in Endovascular Engineering.
-
Who are Endovascular Engineering’s competitors?
Jupiter Endovascular and NeuroVasc Technologies are competitors of Endovascular Engineering.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
